Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer
- PMID: 28202195
- DOI: 10.1016/j.ygyno.2017.02.006
Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer
Abstract
Objective: Evaluate long-term cisplatin-induced ototoxicity in women treated for malignant ovarian germ cell tumors (MOGCT).
Methods: Seventy-four women treated for MOGCT in Norway (1980-2009) were analyzed: 41 had received cisplatin-based chemotherapy (CBCT) ("Cases") and 33 had no CBCT ("Controls"). Median follow-up was 15years. Hearing was assessed by pure tone audiometry and by the SCIN questionnaire. Air conduction thresholds were reported as absolute hearing thresholds and age-adjusted thresholds. Absolute and age-adjusted hearing loss were defined as thresholds of >20dB at any frequency. Tinnitus was evaluated using the Tinnitus Handicap Inventory. Serum Platinum Concentration (SPC) was determined.
Results: Absolute hearing loss was identified in 21 Cases (51%) and 24 Controls (73%). After adjusting for age, only 9 Cases (22%) and 5 Controls (15%) remained. Age-adjusted hearing thresholds at 4, 6 and 8kHz were slightly but significantly higher in Cases compared to Controls. Subjective hearing loss was reported by 27% of Cases and 21% of Controls, who were significantly older. Elevated SPC values were detected up to 20years after CBCT, but SPC did not correlate significantly with age-adjusted hearing loss. The rate of tinnitus was similar in Cases and Controls.
Conclusion: Long-term MOGCT survivors treated with CBCT have small but significant reductions in age-adjusted hearing thresholds at 4, 6 and 8kHz versus Controls. Approximately one in four women experienced subjective hearing loss. To avoid overestimation of clinically relevant cisplatin-induced ototoxicity, absolute hearing thresholds should be age-adjusted and compared to an age-matched control group.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors.Urol Oncol. 2016 Nov;34(11):487.e13-487.e20. doi: 10.1016/j.urolonc.2016.06.012. Epub 2016 Aug 11. Urol Oncol. 2016. PMID: 27523611
-
Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer.J Clin Oncol. 2016 Aug 10;34(23):2712-20. doi: 10.1200/JCO.2016.66.8822. Epub 2016 Jun 27. J Clin Oncol. 2016. PMID: 27354478 Free PMC article.
-
Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study.Acta Oncol. 2018 Aug;57(8):1075-1083. doi: 10.1080/0284186X.2018.1433323. Epub 2018 Jan 31. Acta Oncol. 2018. PMID: 29384420
-
Drug-induced thrombotic microangiopathy after adjuvant chemotherapy in malignant ovarian germ cell tumor: A case report and literature review.Taiwan J Obstet Gynecol. 2024 Nov;63(6):944-947. doi: 10.1016/j.tjog.2024.03.025. Taiwan J Obstet Gynecol. 2024. PMID: 39482010 Review.
-
The long-term impacts of hearing loss, tinnitus and poor balance on the quality of life of people living with and beyond cancer after platinum-based chemotherapy: a literature review.J Cancer Surviv. 2023 Feb;17(1):40-58. doi: 10.1007/s11764-022-01314-9. Epub 2023 Jan 13. J Cancer Surviv. 2023. PMID: 36637633 Free PMC article. Review.
Cited by
-
Surveillance for ototoxicity in platinum-based chemotherapy using mobile health audiometry with extended high frequencies.J Laryngol Otol. 2023 Jan;137(1):61-67. doi: 10.1017/S0022215122001281. Epub 2022 May 25. J Laryngol Otol. 2023. PMID: 35611593 Free PMC article.
-
Cancer survivors and neurotoxic chemotherapy: hearing loss and tinnitus.BMJ Support Palliat Care. 2023 Sep;13(3):345-353. doi: 10.1136/spcare-2022-003684. Epub 2022 Jul 27. BMJ Support Palliat Care. 2023. PMID: 35896321 Free PMC article.
-
Hearing loss and tinnitus in survivors with chemotherapy-induced neuropathy.Eur J Oncol Nurs. 2018 Feb;32:1-11. doi: 10.1016/j.ejon.2017.10.006. Epub 2017 Nov 7. Eur J Oncol Nurs. 2018. PMID: 29353626 Free PMC article.
-
Associations Between Perceived Stress and Chemotherapy-Induced Peripheral Neuropathy and Otoxicity in Adult Cancer Survivors.J Pain Symptom Manage. 2018 Jul;56(1):88-97. doi: 10.1016/j.jpainsymman.2018.02.021. Epub 2018 Mar 7. J Pain Symptom Manage. 2018. PMID: 29524582 Free PMC article.
-
Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: A systematic review and meta-analysis.Cancer Epidemiol. 2022 Aug;79:102203. doi: 10.1016/j.canep.2022.102203. Epub 2022 Jun 17. Cancer Epidemiol. 2022. PMID: 35724557 Free PMC article.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical